DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB17491
| null |
CGX-1321
| null | null | null | null |
DB17492
| null |
Anselamimab
|
2414866-63-8
|
TL94QQ5RTW
|
Anselamimab | Chimeric fibril reactive monoclonal antibody 11-1F4 | IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IMMUNOGLOBULIN LIGHT CHAIN AMYLOID (AL) FIBRILS), CHIMERIC MONOCLONAL ANTIBODY (GAMMA1 HEAVY CHAIN CHIMERIC (1-441) (MUS MUSCULUS VH (IGHV2-3*01 (92.6%)-(IGHD)-IGHJ4*01 (92.9%), CDR-IMGT (8.7.5) (26-33.51-57.96 | Immunoglobulin g1, anti-(human amyloid fibril) (human-mus musculus monoclonal cael-101 .gamma.1-chain), disulfide with human-mus musculus monoclonal cael-101 .kappa.-chain, dimer
| null |
DB17493
| null |
Bioymifi
|
1420071-30-2
| null |
5-(5-((3-(4-bromophenyl)-2-imino-4-oxothiazolidin-5-ylidene)methyl)furan-2-yl)isoindoline-1,3-dione | 5-[5-[(Z)-[3-(4-bromophenyl)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl]furan-2-yl]isoindole-1,3-dione
|
ULBOWKXOFOTCMU-CPEDPXAASA-N
|
DB17494
| null |
Iruplinalkib
|
1854943-32-0
|
Z5F65W1YAZ
|
Iruplinalkib
| null |
DB17495
| null |
Pegenzileukin
|
2573074-47-0
|
10WR240QN7
|
IL-2 variant THOR-707 | Pegylated recombinant interleukin-2 THOR-707
| null |
DB17496
| null |
HPV-16 trojan peptide vaccine
| null | null | null | null |
DB17497
| null |
Autogene cevumeran
|
2365453-34-3
|
L8HDH9IB06
| null | null |
DB17498
| null |
NY-ESO-1 peptide vaccine
| null | null | null | null |
DB17499
| null |
GB1211
|
1978336-95-6
|
94EN2E6BLW
| null |
FNCLKJPMEFPXOR-UHFFFAOYSA-N
|
DB17500
| null |
Vidutolimod
|
147063-80-7
|
D68OW5RS98
|
Cmp-001 component cpg-a oligodeoxynucleotide tlr9 agonist | Dna, d(g-g-g-g-g-g-g-g-g-g-g-a-c-g-a-t-c-g-t-c-g-g-g-g-g-g-g-g-g-g)
| null |
DB17501
| null |
DSP107
| null | null |
SIRPα -4-1BBL
| null |
DB17502
| null |
RO7502175
| null | null | null | null |
DB17503
| null |
PP-F11N lutetium Lu-177
|
1771736-69-6
|
639NVQ0SXF
|
Lutetium lu 177 pp-f11n
|
DTEPIUGEQLNRHF-XMGMVKEQSA-K
|
DB17504
| null |
M-701
| null | null | null | null |
DB17505
| null |
Zimberelimab
|
2259860-24-5
|
ZBL7O904IL
|
Anti-pd-1 monoclonal antibody gls-010 | Immunoglobulin g4(231-proline), anti-(human programmed cell death protein 1) (human monoclonal ab122 .gamma.4-chain), disulfide with human monoclonal ab122 .lambda.-chain, dimer
| null |
DB17506
| null |
Etrumadenant
|
2239273-34-6
|
W0ZE0NT8IF
| null |
BUXIAWLTBSXYSW-UHFFFAOYSA-N
|
DB17507
| null |
COTI-2
|
1039455-84-9
|
2BTA1O65BR
|
1-piperazinecarbothioic acid, 4-(2-pyridinyl)-, 2-(6,7-dihydro-8(5h)-quinolinylidene)hydrazide
|
UTDAKQMBNSHJJB-CJLVFECKSA-N
|
DB17508
| null |
Hafnium oxide
|
12055-23-1
|
3C4Z4KG52T
|
Hafnium oxide-containing nanoparticles nbtxr3
|
WIHZLLGSGQNAGK-UHFFFAOYSA-N
|
DB17509
| null |
UCPVax
| null | null | null | null |
DB17510
| null |
PXS-5505
|
2409963-83-1
|
DO94E28WYW
|
2-buten-1-amine, 3-fluoro-4-(8-quinolinylsulfonyl)-, (2z)-
|
DHXXLGDTPFPYRH-WDZFZDKYSA-N
|
DB17511
| null |
SB 11285
| null | null | null | null |
DB17512
| null |
VB10.16
| null | null |
VB10.16 vaccine
| null |
DB17513
| null |
Casdozokitug
|
2643331-37-5
|
AL6I5N2HTN
|
immunoglobulin G1-kappa, anti-[IL27 (interleukin 27,IL27p28, IL27A)], Homo sapiens monoclonal antibody,gamma1 heavy chain Homo sapiens (1-456) [VH (Homo sapiens IGHV3-21*01 (95.9%) -(IGHD) -IGHJ5*02 (100%), CDR-IMGT [8.8.19] (26-33.51-58.97-115)) (1-126) | Immunoglobulin G1, anti-(human interleukin 27) (human monoclonal SRF388 γ1-chain), disulfide with human monoclonal SRF388 κ-chain, dimer
| null |
DB17514
| null |
Inobrodib
|
2222941-37-7
|
BW5QA5GEW7
|
(s)-1-(3,4-difluorophenyl)-6-(5-(3,5-dimethylisoxazol-4-yl)-1-((1r,4s)-4-methoxycyclohexyl)-1h-benzo(d)imidazol-2-yl)piperidin-2-one | 2-piperidinone, 1-(3,4-difluorophenyl)-6-(5-(3,5-dimethyl-4-isoxazolyl)-1-(trans-4-methoxycyclohexyl)-1h-benzimidazol-2-yl)-, (6s)- | P300/cbp bromodomain inhibitor ccs1477
| null |
DB17515
| null |
Sirexatamab
|
2414962-49-3
|
RM898LZ4SI
|
Anti-dkk-1 monoclonal antibody ly2812176 | Dkk1-neutralizing monoclonal antibody dkn-01 | Immunoglobulin g4 (224-proline,233-alanine,234-alanine), anti-(human dickkopf-1) (human-mus musculus monoclonal dkn-01 .gamma.4-chain), disulfide with human-mus musculus monoclonal dkn-01 .kappa.-chain, dimer
| null |
DB17516
| null |
BMX-001 free base
|
1379866-50-8
|
J06K64323R
|
Manganese(5+), ((2,2',2'',2'''-(21h,23h-porphine-5,10,15,20-tetrayl-.kappa.n21,.kappa.n22,.kappa.n23,.kappa.n24)tetrakis(1-(2-butoxyethyl)pyridiniumato))(2-))-, (sp-4-1)-
|
CZXJDWRMJZZOTQ-UHFFFAOYSA-N
|
DB17517
| null |
Retlirafusp alfa
|
2395839-91-3
|
JP6N6TA92L
|
Immunoglobulin G4 (52-glycine, 57-phenylalanine, 227-proline, 233-alanine, 234-alanine, 446-alanine), anti-(human programmed death-ligand 1) (human-mus musculus monoclonal SHR-1316 .gamma.4-chain) fusion protein with peptide linker ((ggggs)4g) fusion protein with 20-136-type II transforming growth factor .beta. receptor (human isoform 1), disulfide with (85-glutamic acid) human-mus musculus monoclonal SHR-1316 .kappa.-chain, dimer
| null |
DB17518
| null |
GEN-001
| null | null | null | null |
DB17519
| null |
TILT-123
| null | null | null | null |
DB17520
| null |
Vimseltinib
|
1628606-05-2
|
PX9FTM69BF
|
2-(isopropylamino)-3-methyl-5-(6-methyl-5-((2-(1-methyl-1h-pyrazol-4-yl)pyridin-4-yl)oxy)pyridin-2-yl)pyrimidin-4(3h)-one | 3-methyl-2-((1-methylethyl)amino)-5-(6-methyl-5-((2-(1-methyl-1h-pyrazol-4-yl)-4-pyridinyl)oxy)-2-pyridinyl)-4(3h)-pyrimidinone | 4(3h)-pyrimidinone, 3-methyl-2-((1-methylethyl)amino)-5-(6-methyl-5-((2-(1-methyl-1h-pyrazol-4-yl)-4-pyridinyl)oxy)-2-pyridinyl)-
|
TVGAHWWPABTBCX-UHFFFAOYSA-N
|
DB17521
| null |
Domatinostat
|
910462-43-0
|
264ARM7UXX
|
(e)-n-(2-aminophenyl)-3-(1-((4-(1-methyl-1h-pyrazol-4-yl)phenyl)sulfonyl)-1h-pyrrol-3-yl)acrylamide | 2-propenamide, n-(2-aminophenyl)-3-(1-((4-(1-methyl-1h-pyrazol-4-yl)phenyl)sulfonyl)-1h-pyrrol-3-yl)-, (2e)- | Hdac inhibitor 4sc-202
|
PRXXYMVLYKJITB-IZZDOVSWSA-N
|
DB17522
| null |
Batiraxcept
|
2268717-61-7
|
B6840JH4EB
|
AVB-S6-500 | Axl fc fusion protein avb-s6-500
| null |
DB17523
| null |
MRx0518
| null | null | null | null |
DB17524
| null |
KHK2455
| null | null | null | null |
DB17525
| null |
Zanzalintinib
|
2367004-54-2
|
KC2JC2ZA04
|
XL092
|
JSPCKALGNNVYOO-UHFFFAOYSA-N
|
DB17526
| null |
XmAb24306
| null | null |
XmAb 24306 | XmAb-24306
| null |
DB17527
| null |
RO7284755
| null | null |
RO 7284755 | RO-7284755
| null |
DB17528
| null |
ETBX-021
| null |
S4MK9TOL0D
| null | null |
DB17529
| null |
ETBX-051
| null |
BPG11IF0HW
| null | null |
DB17530
| null |
ETBX-061
| null |
17K7SN702N
| null | null |
DB17531
| null |
RO7296682
| null |
HV8TQI2IKP
|
RO 7296682 | RO-7296682
| null |
DB17532
| null |
GI-6207
| null |
FIJ3OLQ3N8
| null | null |
DB17533
| null |
GI-6301
| null |
B0L24T8TB7
| null | null |
DB17534
| null |
TRX-518
|
1427683-53-1
| null | null | null |
DB17535
| null |
RO7300490
| null | null |
RO 7300490 | RO-7300490
| null |
DB17536
| null |
Sirpiglenastat
|
2079939-05-0
|
9GGE6A0ZMK
|
(-)-sirpiglenastat | (s)-isopropyl 2-((s)-2-acetamido-3-(1h-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate | L-norleucine, n-acetyl-l-tryptophyl-6-diazo-5-oxo-, 1-methylethyl ester | Propan-2-yl (2s)-2-((n-acetyl-l-tryptophyl)amino)-6-diazo-5-oxohexanoate
|
LQNMCWOJACNQQM-PMACEKPBSA-N
|
DB17537
| null |
6-diazo-5-oxo-L-norleucine
|
157-03-9
|
03J0H273KZ
| null |
YCWQAMGASJSUIP-YFKPBYRVSA-N
|
DB17538
| null |
Atidarsagene autotemcel
| null |
EPP8G99QG4
|
Atidarsagene autotemcel | Autologous CD34+ cell enriched population that contains haematopoietic stem and progenitor cells (HSPC) transduced ex vivo using a lentiviral vector encoding the human arylsulfatase A (ARSA) gene | Autologous CD34+ cells transduced with lentiviral vector which encodes for the aryl Sulfatase A complimentary deoxyribonucleic acid sequence
| null |
DB17539
| null |
SynOV1.1
| null | null | null | null |
DB17540
| null |
D2C7 immunotoxin
| null | null |
D2C7-immunotoxin | D2C7-IT
| null |
DB17541
| null |
SYNB1891
| null | null | null | null |
DB17542
| null |
Ligufalimab
|
2428381-55-7
|
1S4338NZB8
|
Immunoglobulin g4 (225-proline), anti-(human cd47 antigen) (human-mus musculus monoclonal ak117 .gamma.4-chain), disulfide with human-mus musculus monoclonal ak117 .kappa.-chain, dimer
| null |
DB17543
| null |
PLX51107
|
1627929-55-8
|
W758F1L9ND
|
Benzoic acid, 4-(6-(3,5-dimethyl-4-isoxazolyl)-1-((1s)-1-(2-pyridinyl)ethyl)-1h-pyrrolo(3,2-b)pyridin-3-yl)- | Brd4 inhibitor plx51107
|
AMSUHYUVOVCWTP-UHFFFAOYSA-N
|
DB17544
| null |
Timdarpacept
|
2749520-17-8
|
664WQ5KSP8
|
IMM-01 | IMM01 | Timdarpacept
| null |
DB17545
| null |
Jaktinib
| null | null | null | null |
DB17546
| null |
APR-548
| null | null |
APR 548 | APR548
| null |
DB17547
| null |
Anzurstobart
|
2543693-10-1
|
61FKP5V847
| null | null |
DB17548
| null |
IO-202
| null | null | null | null |
DB17549
| null |
Alrizomadlin
|
1818393-16-6
|
15QAU0SI9J
|
(3'r,4's,5'r)-4-((6-chloro-2-oxo-1,2-dihydro-spiro(indole-3,3'-pyrrolidin)e-4'-(3-chloro-2-fluoro -phenyl)-1'-ethyl-spiro(cyclohexane-1,2'-pyrrolidine)-5'-carbonyl)-amino)-bicyclo(2.2.2)octane-1-carboxylic acid | 4-((3'R,4'S,5'R)-6''-chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2''-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3''-indoline]-5'-carboxamido)bicyclo [2.2.2]octane-1-carboxylic acid | Bicyclo(2.2.2)octane-1-carboxylic acid, 4-((((3'r,4's,5'r)-6''-chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-1'',2''-dihydro-2''-oxodispiro(cyclohexane-1,2'-pyrrolidine-3',3''-(3h)indol)-5'-yl)carbonyl)amino)-
|
YJCZPJQGFSSFOL-MNZPCBJKSA-N
|
DB17550
| null |
PF-04856884
| null |
78LXD26OX3
| null | null |
DB17551
| null |
AGS-16C3F
| null |
VC1D38AGN9
| null | null |
DB17552
| null |
Pucotenlimab
|
2403647-03-8
|
CGA81G3KR5
|
Humanized pd-1 blocking antibody hx-008 | Immunoglobulin g4 (252-theronine,306-proline,432-alanine), anti-(human programmed cell death 1) (human-mus musculus monoclonal hx008 .gamma.4-chain), disulfide with human-mus musculus monoclonal hx008 .kappa.-chain, dimer
| null |
DB17553
| null |
FT-1101
|
1776060-36-6
| null |
FT1101
| null |
DB17554
| null |
FF-10501-01
| null | null |
FF 10501 01 | FF-10501
| null |
DB17555
| null |
SEA-CD70
| null | null |
SEA CD70
| null |
DB17556
| null |
S65487
|
1644600-79-2
|
U4AQZ7WS5X
|
VOB560
| null |
DB17557
| null |
Sovleplenib
|
1415792-84-5
|
9CL6353KHO
| null |
NJIAKNWTIVDSDA-FQEVSTJZSA-N
|
DB17559
| null |
S64315
|
1799631-75-6
|
801XYWHNOS
|
MIK665
| null |
DB17560
| null |
Rineterkib
|
1715025-32-3
|
15KFN616FK
|
4-(3-amino-6-((1s,3s,4s)-3-fluoro-4-hydroxycyclohexyl)-2-pyrazinyl)-n-((1s)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl)-2-fluorobenzamide | Benzamide, 4-(3-amino-6-((1s,3s,4s)-3-fluoro-4-hydroxycyclohexyl)-2-pyrazinyl)-n-((1s)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl)-2-fluoro- | Rineterkib
|
YFCIFWOJYYFDQP-PTWZRHHISA-N
|
DB17561
| null |
Nisevokitug
|
2649854-92-0
|
W2OR26S7UE
|
Anti-tgf-beta monoclonal antibody nis793
| null |
DB17562
| null |
QL1706
| null | null | null | null |
DB17563
| null |
Luveltamab tazevibulin
| null | null | null | null |
DB17564
| null |
Andecaliximab
|
1518996-49-0
|
571045EIM4
|
Immunoglobulin g4, anti-(human gelatinase b) (human-mus musculus monoclonal gs-5745 heavy chain), disulfide with human-mus musculus monoclonal gs-5745 light chain, dimer
| null |
DB17565
| null |
Polyvalent antigen-KLH conjugate vaccine
| null | null | null | null |
DB17566
| null |
GCS-100
| null |
3HO3IZ2ILX
|
Apoptosis inducer GCS-100 | PH-modified pectin (GCS-100)
| null |
DB17567
| null |
INCB052793
| null | null | null | null |
DB17568
| null |
Belvarafenib
|
1446113-23-0
|
31M3WLJ3KG
|
4-amino-n-(1-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno(3,2-d)pyrimidine-7-carboxamide | Belvarafenib | Thieno(3,2-d)pyrimidine-7-carboxamide, 4-amino-n-(1-((3-chloro-2-fluorophenyl)amino)-6-methyl-5-isoquinolinyl)-
|
KVCQTKNUUQOELD-UHFFFAOYSA-N
|
DB17569
| null |
2-O, 3-O desulfated heparin
| null | null | null | null |
DB17570
| null |
Ifebemtinib
|
1227948-82-4
|
C57O858DKU
|
Ifebemtinib
|
ULMMVBPTWVRPSI-UHFFFAOYSA-N
|
DB17571
| null |
Uzansertib
|
2088852-47-3
|
0237X8153Q
|
INCB053914
| null |
DB17572
| null |
Lemzoparlimab
|
2377483-71-9
|
0H2XLR2IKW
|
Immunoglobulin g4(228-proline), anti-(human cd47 antigen) (human monoclonal tj011133 .gamma.4-chain), disulfide with human monoclonal tj011133 .kappa.-chain, dimer
| null |
DB17573
| null |
Evorpacept
|
2484949-51-9
|
X7K762X1IJ
|
A CD47-binding, fusion protein containing a high affinity engineered D1 domain of human signal regulatory protein alpha (SIRPalpha) variant 1 (v1) genetically linked to a modified and inactive Fc domain of human IgG | Cd47/sirpa-blocking agent alx148 | Sirpa variant alx148
| null |
DB17574
| null |
JNJ-75276617
| null | null | null | null |
DB17575
| null |
Utidelone
| null | null | null | null |
DB17576
| null |
Denifanstat
|
1399177-37-7
|
4GF95B2LZA
|
Benzonitrile, 4-(1-(4-cyclobutyl-2-methyl-5-(3-methyl-1h-1,2,4-triazol-5-yl)benzoyl)-4-piperidinyl)-
|
BBGOSBDSLYHMRA-UHFFFAOYSA-N
|
DB17577
| null |
Crefmirlimab
|
2611099-93-3
|
PTO7SXB9L7
|
Iab22m2c (antibody fragment against the human cd8-antigen on cd8-positive t-cells) | Imaginab
| null |
DB17578
| null |
TTI-101
|
432001-19-9
|
KZ3DLD11RQ
|
Benzenesulfonamide, n-(1',2-dihydroxy(1,2'-binaphthalen)-4'-yl)-4-methoxy- | Stat3 inhibitor c188-9 | Stat3 inhibitor tti-101
|
QDCJDYWGYVPBDO-UHFFFAOYSA-N
|
DB17579
| null |
SS1(dsFv)-PE38
| null | null |
SS1 (dsFv) PE38 | SS1(dsFv) PE38 | SS1(dsFv)-PE38 immunotoxin
| null |
DB17580
| null |
DCVax-L
| null | null | null | null |
DB17581
| null |
Ad-CEA vaccine
| null | null | null | null |
DB17582
| null |
Exarafenib
|
2639957-39-2
|
2VPX8HL8AB
|
KIN-2787 free base
|
GZMYLSJUNSCMTD-MOPGFXCFSA-N
|
DB17583
| null |
OKI-179
| null | null | null | null |
DB17584
| null |
Mezigdomide
|
2259648-80-9
|
LA88IH4O02
|
4-(4-((4-(((2-((3s)-2,6-dioxopiperidin-3-yl)-1-oxo-2,3-dihydro-1h-isoindol-4- yl)oxy)methyl)phenyl)methyl)piperazin-1-yl)-3-fluorobenzonitrile | Benzonitrile, 4-(4-((4-(((2-((3s)-2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1h-isoindol-4-yl)oxy)methyl)phenyl)methyl)-1-piperazinyl)-3-fluoro-
|
YTINZZFBHWSAGL-NDEPHWFRSA-N
|
DB17585
| null |
Immunocytokine NHS-IL12
|
1807503-77-0
|
KF6D9Z1MER
| null | null |
DB17586
| null |
ABBV-514
| null | null | null | null |
DB17587
| null |
KIN-3248
| null | null | null | null |
DB17588
| null |
Rocapuldencel-T
| null |
8I9S6401XZ
|
Rocapuldencel-T
| null |
DB17589
| null |
Loxoribine
|
121288-39-9
|
9CAS0V66OI
|
7-Allyl-7,8-dihydro-8-oxoguanosine
|
VDCRFBBZFHHYGT-IOSLPCCCSA-N
|
DB17590
| null |
PEG-interleukin-2
| null | null |
Polyethylene glycol-modified recombinant interleukin-2
| null |
DB17591
| null |
Picibanil
|
39325-01-4
|
2F42BH7X2L
| null | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.